What is it about?
This paper compiles the most promising epigenetic-based biomarkers for clinical management of testicular cancer
Featured Image
Why is it important?
It provides a starting point for clinical validation of candidate biomarkers and it identifies the most promising areas to be explored
Perspectives
This is a very importante publication for me as it constitutes the first paper from our research team entirely dedicated to testicular germ cell tumors and it inaugurates a novel research line.
Rui Henrique
Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E.
Read the Original
This page is a summary of: The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers, Epigenomics, February 2017, Future Medicine,
DOI: 10.2217/epi-2016-0081.
You can read the full text:
Contributors
The following have contributed to this page
